Complete Story
 

08/23/2021

FDA Grants Full Approval to the Pfizer COVID-19 Vaccine

The decision will likely set off a cascade of vaccine requirements

The Food and Drug Administration (FDA) on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and up, making it the first to move beyond emergency use status in the United States.

The decision will set off a cascade of vaccine requirements by hospitals, colleges, corporations and other organizations. United Airlines recently announced that its employees will be required to show proof of vaccination within five weeks of regulatory approval.

Oregon has adopted a similar requirement for all state workers, as have a host of universities in states from Louisiana to Minnesota. The Pentagon has said it would mandate the shots for the country’s 1.3 million active-duty troops once the Pfizer approval came through.

Please select this link to read the complete article from The New York Times.

Printer-Friendly Version